GREGORY M. DROZDZAL

ASSOCIATE

Greg Drozdzal is an associate in Kleinberg Kaplan’s Corporate Transactional & Finance Group. He represents public and private companies, investors and financial intermediaries in a wide variety of capital raising transactions, including venture financings, IPOs, registered “shelf takedown” and secondary offerings, private placements (including PIPEs and Rule 144A/Reg S offerings of convertible and non-convertible debt securities) and “at-the-market” continuous offerings. Greg also advises on M&A transactions, recapitalizations and joint ventures, as well as corporate governance, compliance with SEC and stock exchange rules and general securities law matters.

Practices

About

Prior to joining Kleinberg Kaplan, Greg was an associate in the corporate and capital markets practices of leading international law firms in New York, Boston and Toronto. He also served on secondment to the Investment Banking Legal division of a global investment bank, where he supported bankers on financial advisory engagements and the bank’s corporate trading desk on share repurchase transactions.

Formerly an M.D./scientist, Greg brings a clinical perspective to his work for clients in the life sciences and healthcare sectors, including on due diligence and disclosure relating to pharmaceuticals, medical devices and clinical trials.

Education

University of Toronto Faculty of Law (J.D., 2020)

Angus MacMurchy Gold Medal and Gallant Ho Prize

University of Ottawa Faculty of Medicine (M.D., 2015)

Bar Admissions

2025, New York

2022, Massachusetts